Search Result
List
2017-06-15 - 2025-12-31
Phase III
-
Condition/Disease
Metastatic Castrate-Resistant Prostate Cancer
-
Test Drug
IPATASERTIB
Participate Sites
6Sites
Terminated4Sites
2016-01-01 - 2019-08-31
Phase III
-
Condition/Disease
Non-Small Cell Lung Cancer (NSCLC)
-
Test Drug
AZD9291
Participate Sites
9Sites
Terminated8Sites
Division of Hematology & Oncology
2018-06-01 - 2022-11-15
Phase I
-
Condition/Disease
Advanced Malignancies
-
Test Drug
Isatuximab
Participate Sites
7Sites
Not yet recruiting1Sites
Recruiting5Sites
Division of Hematology & Oncology
2015-08-01 - 2017-07-31
Phase III
-
Condition/Disease
rheumatoid arthritis (RA) who had an inadequate response to DMARDs
-
Test Drug
ASP015K
Participate Sites
11Sites
Terminated10Sites
Division of Rheumatology
2015-11-01 - 2019-12-31
Phase III
-
Condition/Disease
Type 2 Diabetes Mellitus
-
Test Drug
Bexagliflozin Tablets
Participate Sites
9Sites
Terminated7Sites
2016-06-01 - 2025-05-31
IITPhase III
-
Condition/Disease
Triple Negative Locally Advanced Breast Cancer
-
Test Drug
atezolizumab (MPDL3280A)
Participate Sites
7Sites
Terminated5Sites
Division of General Surgery
2016-03-01 - 2017-07-31
Phase II
-
Condition/Disease
Influenza A
-
Test Drug
MHAA4549A
Participate Sites
5Sites
Study ended4Sites
Division of Infectious Disease
2016-08-01 - 2024-12-31
Phase III
-
Condition/Disease
Metastatic Hormone Sensitive Prostate Cancer (mHSPC)
-
Test Drug
Xtandi® Soft Capsules 40 mg
Participate Sites
6Sites
Terminated5Sites
Division of Hematology & Oncology
2017-02-17 - 2020-12-17
Phase III
-
Condition/Disease
Crohn’s Disease
-
Test Drug
Filgotinib
Participate Sites
13Sites
Recruiting8Sites
Terminated3Sites
Division of General Internal Medicine
2014-12-30 - 2019-12-31
Phase III
-
Condition/Disease
major adverse cardiovascular event, MACE
-
Test Drug
Epanova®
Participate Sites
7Sites
Terminated6Sites
